Pure Biologics Spólka Akcyjna (PUR.WA)

PLN 9.19

(-3.26%)

Operating Income Summary of Pure Biologics Spólka Akcyjna

  • Pure Biologics Spólka Akcyjna's latest annual operating income in 2023 was -31.71 Million PLN , down -28.78% from previous year.
  • Pure Biologics Spólka Akcyjna's latest quarterly operating income in 2024 Q2 was 486 Thousand PLN , up 110.56% from previous quarter.
  • Pure Biologics Spólka Akcyjna reported an annual operating income of -24.62 Million PLN in 2022, down -134.96% from previous year.
  • Pure Biologics Spólka Akcyjna reported an annual operating income of -10.48 Million PLN in 2021, up 9.29% from previous year.
  • Pure Biologics Spólka Akcyjna reported a quarterly operating income of -4.6 Million PLN for 2024 Q1, up 53.3% from previous quarter.
  • Pure Biologics Spólka Akcyjna reported a quarterly operating income of -6.25 Million PLN for 2023 Q3, up 32.81% from previous quarter.

Annual Operating Income Chart of Pure Biologics Spólka Akcyjna (2023 - 2016)

Historical Annual Operating Income of Pure Biologics Spólka Akcyjna (2023 - 2016)

Year Operating Income Operating Income Growth
2023 -31.71 Million PLN -28.78%
2022 -24.62 Million PLN -134.96%
2021 -10.48 Million PLN 9.29%
2020 -11.55 Million PLN -164.62%
2019 -4.36 Million PLN -592.05%
2018 -631.01 Thousand PLN -63.37%
2017 -386.24 Thousand PLN 7.92%
2016 -419.45 Thousand PLN 0.0%

Peer Operating Income Comparison of Pure Biologics Spólka Akcyjna

Name Operating Income Operating Income Difference
Bioceltix S.A. -15.81 Million PLN -100.499%
BIOTON S.A. 15.29 Million PLN 307.375%
Captor Therapeutics Spolka Akcyjna -73.01 Million PLN 56.56%
Mabion S.A. 55.06 Million PLN 157.605%
Molecure S.A. -22.1 Million PLN -43.496%
NanoGroup S.A. -7.9 Million PLN -301.397%
Pharmena S.A. 34.87 Million PLN 190.958%
Poltreg S.A. -16.86 Million PLN -88.103%
Ryvu Therapeutics S.A. -100.94 Million PLN 68.58%
Synthaverse S.A. 8.64 Million PLN 466.809%
Urteste S.A. -6.44 Million PLN -391.981%